Titan Pharma (TTNP) Misses Q4 EPS by 1c

Titan Pharma (NASDAQ: TTNP) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Titan Pharma (TTNP) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
• Associated Banc-Corp (ASB) Tops Q1 EPS by 3c